Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/30434
Title: Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas
Authors: Ata, Barış
Namusoğlu, Sezcan
Seyhan, Ayşe
Kaspoğlu, Işıl
Urman, Bülent
Bozdağ, Gürkan
Uludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı.
0000-0002-9277-7735
Aslan, Kiper
Avcı, Berrin
Uncu, Gürkan
AER-7173-2022
AAH-9694-2021
ABE-6685-2020
AAT-3479-2021
56740498500
55769899600
6603716169
Keywords: Obstetrics & gynecology
Reproductive biology
Assisted reproduction
Endometriosis
Infertility
Live birth
Ovarian reserve
Necurrent endometrioma
Ovarian reserve
Impact
Excision
Ivf
Surgery
Removal
Cycles
Issue Date: 3-May-2017
Publisher: Oxford University
Citation: Ata, B. vd. (2017). ''Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas''. Human Reproduction, 32(7), 1427-1431.
Abstract: Are live birth rates (LBR) different after ART cycles between women with primary or recurrent endometrioma? Women with recurrent endometrioma have similar LBR as compared to patients with primary endometrioma. Recurrence rate can be as high as 29% after endometrioma excision. Prior studies on management of endometrioma before ART involve primary endometriomas. There is limited information regarding the prognosis of women with recurrent endometriomas. A multicenter retrospective cohort study, including 76 women with primary and 82 women with recurrent endometriomas treated at the participating centers over a 6-year period. Women with endometrioma who underwent ART at three academic ART centers. Couples with another indication for ART were excluded. Female age, median number of prior failed ART cycles, proportion of patients with bilateral endometrioma (28 versus 28.9%), ovarian stimulation protocols, and total gonadotropin consumption were similar between the study groups. Numbers of metaphase two oocytes (5 versus 6), number of embryos transferred, and the proportion of patients undergoing blastocyst transfer were similar across the study groups. Clinical pregnancy rates (36.6 versus 34.2%, absolute difference 2.4%, 95% CI: -12.5 to 17.3%, P = 0.83) and LBR (35.4 versus 30.3%, absolute difference 5.1%, 95% CI: -9.5 to 19.7%, P = 0.51) per started cycle in recurrent and primary endometrioma were similar. Comparable success rates were also confirmed with logistic regression analysis (OR: 1.14, 95% CI: 0.78-0.57, P = 2.3) The retrospective design has inherent limitations. Some women with severely decreased ovarian reserve after primary endometrioma excision may not have pursued further treatment. The management of endometrioma prior to ART is controversial but a different management strategy is not required for recurrent endometriomas. Since recurrent endometriomas do not have a worse impact on ART outcome than primary endometriomas, and repeat surgery has a higher risk for complications, conservative management without surgery can be justified.
URI: https://doi.org/10.1093/humrep/dex099
https://academic.oup.com/humrep/article/32/7/1427/3819244
1460-2350
http://hdl.handle.net/11452/30434
ISSN: 0268-1161
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Eslan_vd_2017.pdf145.08 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons